HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology37 papers

Gonococcal female pelvic infection

Last edited: 4/15/2026

Overview

Gonococcal female pelvic infection involves the spread of Neisseria gonorrhoeae into the female pelvic organs, often complicating sexually transmitted infections and posing significant risks, particularly in pregnant and postoperative women 1.

Diagnosis

  • Clinical Manifestations: Fever, lower abdominal pain, abnormal vaginal discharge, and cervical motion tenderness 1.
  • Laboratory Testing: Gram stain and culture of endocervical or vaginal specimens to identify N. gonorrhoeae 1.
  • Imaging: Considered if clinical suspicion remains high despite negative initial tests, to assess for abscesses or other complications 1.

    • Management

  • First-Line Treatment: Recommended treatment involves a combination of antibiotics effective against N. gonorrhoeae, such as ceftriaxone (250 mg intramuscularly) plus azithromycin (1 g orally) 1.
  • Adjunctive Measures: Supportive care including hydration, pain management, and monitoring for signs of sepsis or shock 1.

    • Special Populations

  • Pregnancy: Careful monitoring is crucial due to potential risks of septic shock and severe maternal morbidity; prompt and appropriate antimicrobial therapy is essential 1.
  • Comorbidities: No specific guidance provided in abstracts; however, comorbid conditions may necessitate tailored management approaches 1.

    • Key Recommendations

  • Prompt Diagnosis and Treatment: Early recognition and aggressive management of pelvic infections, especially in high-risk groups like pregnant and postoperative women, are critical to prevent severe complications (Evidence: Strong 1).
  • Antibiotic Therapy: Use ceftriaxone plus azithromycin as first-line therapy for gonococcal pelvic infections (Evidence: Strong 1).
  • Avoid Unnecessary Antibiotics: Antibiotic prophylaxis is not necessary during intrauterine device insertion due to the low risk of pelvic infection (Evidence: Moderate 2).

    • References

    1 Soper DE. Early recognition of serious infections in obstetrics and gynecology. Clinical obstetrics and gynecology 2012. link 2 . Intrauterine devices: antibiotic prophylaxis not necessary during insertion. Prescrire international 2001. link

    Original source

    1. [1]
      Early recognition of serious infections in obstetrics and gynecology. — Soper DE Clinical obstetrics and gynecology (2012)
    2. [2]
      Intrauterine devices: antibiotic prophylaxis not necessary during insertion. Prescrire international (2001)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG